Bank of America
INBS icon

Bank of America’s Intelligent Bio Solutions INBS Stock Holding History

Bank of America’s Portfolio INBS Stock Details INBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-9
Closed -$86 – 6280
2025
Q4 		$86 Buy
9
+3
+50% +$24 ﹤0.01% 6847
2025
Q3 		$65 Hold
6
– – ﹤0.01% 7953
2025
Q2 		$108 Buy
6
+1
+20% +$14 ﹤0.01% 7956
2025
Q1 		$65 Buy
5
+1
+25% +$19 ﹤0.01% 7916
2024
Q4 		$50 Buy
4
+1
+33% +$15 ﹤0.01% 7862
2024
Q3 		$43 Hold
3
– – ﹤0.01% 7860
2024
Q2 		$48 Buy
+3
New +$77 ﹤0.01% 7845

Other funds holding INBS

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
CW
Curio Wealth Annapolis, Maryland $293M AUM 14.23% 1-Year Est. Return

Bank of America's INBS Position: Q1 2026 in Review

Bank of America sold out of Intelligent Bio Solutions (INBS) in Q1 2026, closing a stake of 9 shares — an estimated $86 sold.

Bank of America first reported a position in INBS in Q2 2024 and held it in 7 quarters. The position peaked at $108 in Q2 2025. 9 funds tracked by Wall St. Rank hold INBS as of Q1 2026.

  • Bank of America reported no remaining Intelligent Bio Solutions position as of Q1 2026 after selling out during the quarter.
  • Bank of America sold 9 Intelligent Bio Solutions shares in Q1 2026, an estimated $86.
  • Bank of America first reported a position in Intelligent Bio Solutions in Q2 2024 and held it in 7 quarters.
  • Bank of America's Intelligent Bio Solutions position peaked at $108 in Q2 2025.
  • 9 funds tracked by Wall St. Rank held Intelligent Bio Solutions as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.